Analyst Ratings for Aptevo Therapeutics (APVO)
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2023 | Alliance Global Partners | James Molloy | New Coverage | Buy (N/A) |
N/A (N/A) |
0.33 (0.68) |
106.06% | Details |
| 3/4/2020 | Roth/MKM » Updated 11/9/2020 |
Jonathan Aschoff | New Coverage | Buy (N/A) |
64.00 (42.00) |
0.39 (0.68) |
74.36% | Details |
 |
||||||||
|
||||||||
